Neuromuscular rate of force development deficit in Parkinson disease

Kelley G. Hammond, Ronald Pfeiffer, Mark S. LeDoux, Brian K. Schilling

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background Bradykinesia and reduced neuromuscular force exist in Parkinson disease. The interpolated twitch technique has been used to evaluate central versus peripheral manifestations of neuromuscular strength in healthy, aging, and athletic populations, as well as moderate to advanced Parkinson disease, but this method has not been used in mild Parkinson disease. This study aimed to evaluate quadriceps femoris rate of force development and quantify potential central and peripheral activation deficits in individuals with Parkinson disease. Methods Nine persons with mild Parkinson Disease (Hoehn & Yahr ≤ 2, Unified Parkinson Disease Rating Scale total score = mean 19.1 (SD 5.0)) and eight age-matched controls were recruited in a cross-sectional investigation. Quadriceps femoris voluntary and stimulated maximal force and rate of force development were evaluated using the interpolated twitch technique. Findings Thirteen participants satisfactorily completed the protocol. Individuals with early Parkinson disease (n = 7) had significantly slower voluntary rate of force development (p = 0.008; d = 1.97) and rate of force development ratio (p = 0.004; d = 2.18) than controls (n = 6). No significant differences were found between groups for all other variables. Interpretations Persons with mild-to-moderate Parkinson disease display disparities in rate of force development, even without deficits in maximal force. The inability to produce force at a rate comparable to controls is likely a downstream effect of central dysfunction of the motor pathway in Parkinson disease.

Original languageEnglish (US)
Pages (from-to)14-18
Number of pages5
JournalClinical Biomechanics
Volume45
DOIs
StatePublished - Jun 1 2017

Fingerprint

Parkinson Disease
Quadriceps Muscle
Neuromuscular Manifestations
Efferent Pathways
Hypokinesia
Sports
Population

Keywords

  • Central activation
  • Rate of force development
  • Skeletal muscle
  • Weakness

ASJC Scopus subject areas

  • Biophysics
  • Orthopedics and Sports Medicine

Cite this

Neuromuscular rate of force development deficit in Parkinson disease. / Hammond, Kelley G.; Pfeiffer, Ronald; LeDoux, Mark S.; Schilling, Brian K.

In: Clinical Biomechanics, Vol. 45, 01.06.2017, p. 14-18.

Research output: Contribution to journalArticle

Hammond, Kelley G. ; Pfeiffer, Ronald ; LeDoux, Mark S. ; Schilling, Brian K. / Neuromuscular rate of force development deficit in Parkinson disease. In: Clinical Biomechanics. 2017 ; Vol. 45. pp. 14-18.
@article{8ea96485d16841fbbca51469b1d9b542,
title = "Neuromuscular rate of force development deficit in Parkinson disease",
abstract = "Background Bradykinesia and reduced neuromuscular force exist in Parkinson disease. The interpolated twitch technique has been used to evaluate central versus peripheral manifestations of neuromuscular strength in healthy, aging, and athletic populations, as well as moderate to advanced Parkinson disease, but this method has not been used in mild Parkinson disease. This study aimed to evaluate quadriceps femoris rate of force development and quantify potential central and peripheral activation deficits in individuals with Parkinson disease. Methods Nine persons with mild Parkinson Disease (Hoehn & Yahr ≤ 2, Unified Parkinson Disease Rating Scale total score = mean 19.1 (SD 5.0)) and eight age-matched controls were recruited in a cross-sectional investigation. Quadriceps femoris voluntary and stimulated maximal force and rate of force development were evaluated using the interpolated twitch technique. Findings Thirteen participants satisfactorily completed the protocol. Individuals with early Parkinson disease (n = 7) had significantly slower voluntary rate of force development (p = 0.008; d = 1.97) and rate of force development ratio (p = 0.004; d = 2.18) than controls (n = 6). No significant differences were found between groups for all other variables. Interpretations Persons with mild-to-moderate Parkinson disease display disparities in rate of force development, even without deficits in maximal force. The inability to produce force at a rate comparable to controls is likely a downstream effect of central dysfunction of the motor pathway in Parkinson disease.",
keywords = "Central activation, Rate of force development, Skeletal muscle, Weakness",
author = "Hammond, {Kelley G.} and Ronald Pfeiffer and LeDoux, {Mark S.} and Schilling, {Brian K.}",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/j.clinbiomech.2017.04.003",
language = "English (US)",
volume = "45",
pages = "14--18",
journal = "Clinical Biomechanics",
issn = "0268-0033",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Neuromuscular rate of force development deficit in Parkinson disease

AU - Hammond, Kelley G.

AU - Pfeiffer, Ronald

AU - LeDoux, Mark S.

AU - Schilling, Brian K.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Background Bradykinesia and reduced neuromuscular force exist in Parkinson disease. The interpolated twitch technique has been used to evaluate central versus peripheral manifestations of neuromuscular strength in healthy, aging, and athletic populations, as well as moderate to advanced Parkinson disease, but this method has not been used in mild Parkinson disease. This study aimed to evaluate quadriceps femoris rate of force development and quantify potential central and peripheral activation deficits in individuals with Parkinson disease. Methods Nine persons with mild Parkinson Disease (Hoehn & Yahr ≤ 2, Unified Parkinson Disease Rating Scale total score = mean 19.1 (SD 5.0)) and eight age-matched controls were recruited in a cross-sectional investigation. Quadriceps femoris voluntary and stimulated maximal force and rate of force development were evaluated using the interpolated twitch technique. Findings Thirteen participants satisfactorily completed the protocol. Individuals with early Parkinson disease (n = 7) had significantly slower voluntary rate of force development (p = 0.008; d = 1.97) and rate of force development ratio (p = 0.004; d = 2.18) than controls (n = 6). No significant differences were found between groups for all other variables. Interpretations Persons with mild-to-moderate Parkinson disease display disparities in rate of force development, even without deficits in maximal force. The inability to produce force at a rate comparable to controls is likely a downstream effect of central dysfunction of the motor pathway in Parkinson disease.

AB - Background Bradykinesia and reduced neuromuscular force exist in Parkinson disease. The interpolated twitch technique has been used to evaluate central versus peripheral manifestations of neuromuscular strength in healthy, aging, and athletic populations, as well as moderate to advanced Parkinson disease, but this method has not been used in mild Parkinson disease. This study aimed to evaluate quadriceps femoris rate of force development and quantify potential central and peripheral activation deficits in individuals with Parkinson disease. Methods Nine persons with mild Parkinson Disease (Hoehn & Yahr ≤ 2, Unified Parkinson Disease Rating Scale total score = mean 19.1 (SD 5.0)) and eight age-matched controls were recruited in a cross-sectional investigation. Quadriceps femoris voluntary and stimulated maximal force and rate of force development were evaluated using the interpolated twitch technique. Findings Thirteen participants satisfactorily completed the protocol. Individuals with early Parkinson disease (n = 7) had significantly slower voluntary rate of force development (p = 0.008; d = 1.97) and rate of force development ratio (p = 0.004; d = 2.18) than controls (n = 6). No significant differences were found between groups for all other variables. Interpretations Persons with mild-to-moderate Parkinson disease display disparities in rate of force development, even without deficits in maximal force. The inability to produce force at a rate comparable to controls is likely a downstream effect of central dysfunction of the motor pathway in Parkinson disease.

KW - Central activation

KW - Rate of force development

KW - Skeletal muscle

KW - Weakness

UR - http://www.scopus.com/inward/record.url?scp=85017517354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017517354&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiomech.2017.04.003

DO - 10.1016/j.clinbiomech.2017.04.003

M3 - Article

C2 - 28432901

AN - SCOPUS:85017517354

VL - 45

SP - 14

EP - 18

JO - Clinical Biomechanics

JF - Clinical Biomechanics

SN - 0268-0033

ER -